PubRank

Toru Satoh

Author PubWeight™ 46.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation 2013 2.64
2 Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012 1.51
3 Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy. Circ J 2012 1.45
4 A 19-year-old man with myocardial infarction and sitosterolemia. Intern Med 2003 1.44
5 Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol. Intern Med 2004 1.41
6 Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension. Circ J 2012 1.41
7 Significance of electrocardiographic right ventricular hypertrophy in patients with pulmonary hypertension with or without right ventricular systolic dysfunction. Intern Med 2012 1.38
8 Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 2013 1.26
9 A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis. Keio J Med 2004 1.05
10 Serum C-reactive protein elevation predicts poor clinical outcome in patients with distal type acute aortic dissection: association with the occurrence of oxygenation impairment. Int J Cardiol 2005 1.00
11 Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. PLoS One 2012 0.95
12 Pulmonary hypertension and thalidomide therapy in multiple myeloma. Br J Haematol 2005 0.90
13 Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J 2002 0.90
14 A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 2008 0.88
15 Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction--role of neurohormones and cytokines. Int J Cardiol 2003 0.87
16 Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 2003 0.87
17 Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension. Respirology 2013 0.85
18 Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int J Rheumatol 2010 0.85
19 Quantitative analysis of right ventricular function in patients with pulmonary hypertension using three-dimensional echocardiography and a two-dimensional summation method compared to magnetic resonance imaging. Am J Cardiol 2011 0.85
20 Alu-mediated nonallelic homologous and nonhomologous recombination in the BMPR2 gene in heritable pulmonary arterial hypertension. Genet Med 2013 0.84
21 Gene transfer therapy by either type 1 or type 2 adeno-associated virus expressing human prostaglandin I2 synthase gene is effective for treatment of pulmonary arterial hypertension. J Cardiovasc Pharmacol Ther 2012 0.84
22 Exercise training without ventricular remodeling in patients with moderate to severe left ventricular dysfunction early after acute myocardial infarction. Int J Cardiol 2003 0.84
23 "Double-stick tape" technique for transposition of an offending vessel in microvascular decompression: technical case report. Neurosurgery 2011 0.84
24 Noninvasive Positive Pressure Ventilation against Reperfusion Pulmonary Edema following Percutaneous Transluminal Pulmonary Angioplasty. Case Rep Anesthesiol 2012 0.83
25 Percutaneous transluminal pulmonary angioplasty for central-type chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv 2013 0.83
26 Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure. J Card Fail 2007 0.83
27 Percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension with severe right heart failure. Am J Respir Crit Care Med 2014 0.83
28 Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice. PLoS One 2012 0.82
29 Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy. Circ J 2012 0.82
30 Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension. Am J Respir Crit Care Med 2012 0.82
31 Evaluation of ischemic heart disease on a 1.5 Tesla scanner: combined first-pass perfusion and viability study. Radiat Med 2005 0.82
32 Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm. J Vasc Surg 2002 0.81
33 Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol. Circ J 2005 0.81
34 Efficacy of 360-degree three-dimensional rotational pulmonary angiography to guide percutaneous transluminal pulmonary angioplasty. EuroIntervention 2014 0.81
35 Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension　- Insights From the IBUKI and AIR Studies. Circ J 2016 0.81
36 A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med 2005 0.80
37 Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure. Cardiovasc Drugs Ther 2005 0.80
38 AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice. Biochem Biophys Res Commun 2007 0.80
39 Aging adversely affects postinfarction inflammatory response and early left ventricular remodeling after reperfused acute anterior myocardial infarction. Cardiology 2005 0.79
40 Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology (Oxford) 2012 0.79
41 Left ventricular dysfunction due to diffuse multiple vessel coronary artery spasm can be concealed in dilated cardiomyopathy. Eur J Heart Fail 2012 0.78
42 Diversity of Lesion Morphology in CTEPH Analyzed by OCT, Pressure Wire, and Angiography. JACC Cardiovasc Imaging 2015 0.78
43 Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ J 2002 0.78
44 Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients. Curr Med Res Opin 2007 0.78
45 [Definitions and diagnosis of pulmonary hypertension]. Turk Kardiyol Dern Ars 2014 0.77
46 De novo mutations in the BMPR2 gene in patients with heritable pulmonary arterial hypertension. Ann Hum Genet 2015 0.77
47 Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 2002 0.77
48 Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center. Mod Rheumatol 2013 0.77
49 Effect of preinfarction angina pectoris on ST-segment resolution after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2002 0.76
50 Medical therapy of chronic thromboembolic pulmonary hypertension. Circ J 2013 0.75
51 Evaluation of a new formulation of epoprostenol sodium in Japanese patients with pulmonary arterial hypertension (EPITOME4). Adv Ther 2013 0.75
52 Correction: Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension. PLoS One 2015 0.75
53 [Preoperative assessment of microvascular decompression for hemifacial spasm with fusion imaging of 3D MR cisternogram/angiogram]. No Shinkei Geka 2006 0.75
54 Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure. Circ J 2008 0.75
55 O2 extraction during exercise determines training effect after cardiac rehabilitation in myocardial infarction. Circ J 2002 0.75
56 Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure. J Card Fail 2004 0.75
57 A case of dilated cardiomyopathy with end-stage heart failure treated by prolonged continuous hemodiafiltration. Keio J Med 2002 0.75
58 IgD myeloma with systemic amyloidosis with chest discomfort as an initial symptom. Keio J Med 2004 0.75
59 Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy. J Clin Anesth 2012 0.75
60 Sorafenib is effective in the treatment of pulmonary veno-occlusive disease. Cardiology 2012 0.75
61 Massive ascites in pulmonary arterial hypertension: caution with epoprostenol. Ann Am Thorac Soc 2013 0.75
62 IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment. Eur Respir J 2014 0.75
63 Recovery of cardiac function after living-donor lung transplantation in a patient with primary pulmonary hypertension. Circ J 2002 0.75
64 Successful Treatment of Severe Right-Sided Heart Failure Due to Postoperative Constrictive Pericarditis With Tolvaptan. Am J Ther 2016 0.75
65 [Transluminal imaging of three-dimensional CT and MR angiograms for transluminal observation of angioarchitecture of cerebral aneurysms]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2002 0.75
66 Beta-blockers are effective in congestive heart failure patients with atrial fibrillation. J Card Fail 2003 0.75
67 Evaluation of contour of unruptured cerebral aneurysm using three-dimensional CT cisternogram. Acta Med Okayama 2004 0.75